Drug Treatment for Alcoholics With Post-Traumatic Stress Disorder
This study will investigate the use of sertraline (Zoloft) to decrease alcohol consumption and crime-related post-traumatic stress disorder in those individuals with both disorders. This will be a 12-week, placebo-controlled, double-blind outpatient trial.
All subjects will receive cognitive behavioral therapy in addition to a placebo or sertraline. Comprehensive evaluation will be done at study entry; treatment termination; and 6, 9, and 12 months after study entry.
Post-Traumatic Stress Disorder
Drug: sertraline (Zoloft)
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Primary Purpose: Treatment
|Official Title:||Sertraline Treatment in Comorbid Post-Traumatic Stress Disorder and Alcoholism|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000446
|United States, South Carolina|
|Department of Psychiatry and Behavioral Science, Medical University of South Carolina|
|Charleston, South Carolina, United States, 29425|